1
|
Iovoli AJ, Yu H, Advani PG, Turecki L, Malhotra HK, Malik NK, Fung-Kee-Fung S, Singh AK, Farrugia MK. Sinoatrial Node Dose Is Associated With Worse Survival in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Cancers. Pract Radiat Oncol 2024; 14:e40-e47. [PMID: 37804882 DOI: 10.1016/j.prro.2023.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 09/22/2023] [Accepted: 09/26/2023] [Indexed: 10/09/2023]
Abstract
PURPOSE Our purpose was to evaluate the clinical consequences of sinoatrial node (SAN) and atrioventricular node (AVN) irradiation in patients undergoing stereotactic body radiation therapy (SBRT) for central non-small cell lung cancer (NSCLC) tumors. METHODS AND MATERIALS A single-institutional retrospective review of patients with primary NSCLC undergoing definitive SBRT for centrally located thoracic tumors from February 2007 to December 2021 was performed. The SAN and AVN were contoured in accordance with a published contouring atlas, and the maximum dose (Dmax) and mean dose (Dmean) for each structure were calculated. Sequential log rank testing between the 50th and 90th percentiles was used to identify potential cutoff values for the corresponding dosimetric parameters and overall survival. RESULTS Among 93 eligible patients, the median age was 72.5 years (IQR, 66.6-78.3), and median follow-up was 32.4 months (IQR, 13.0-49.6). The median SAN Dmax and Dmean were 95 cGy (range, 9-5394) and 58 cGy (range, 7-3168), respectively. The median AVN Dmax and Dmean were 45 cGy (range, 4-2121) and 34 cGy (range, 3-1667), respectively. Candidate cutoff values for SAN Dmax and Dmean were 1309 and 836 cGy, respectively. No associations between AVN parameters and survival outcomes were identified. Upon multivariate Cox regression, the SAN Dmax cutoff (hazard ratio [HR], 2.03 [1.09-3.79]; P = .026) and SAN Dmean cutoff (HR, 2.22 [1.20-4.12]; P = .011) were significantly associated with overall survival. For noncancer-associated survival, the SAN Dmax cutoff trended toward significance (HR, 2.02 [0.89-4.57]; P = .092), and the SAN Dmean cutoff remained significantly associated (HR, 2.34 [1.05-5.18]; P = .037). CONCLUSIONS For patients undergoing SBRT for NSCLC, SAN Dmax and Dmean were significantly associated with worse overall survival using cut-off values of 1309 and 836 cGy, respectively. Further studies examining the effect of SAN irradiation during SBRT are warranted.
Collapse
Affiliation(s)
| | - Han Yu
- Biostatistics & Bioinformatics
| | - Pragati G Advani
- Internal Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York
| | - Lauren Turecki
- Jacobs School of Medicine and Biomedical Sciences University at Buffalo, Buffalo, New York
| | | | | | | | | | | |
Collapse
|
2
|
Iovoli AJ, Prasad S, Malhotra HK, Malik NK, Fung-Kee-Fung S, Singh AK, Farrugia MK. Brachial Plexopathy After Single-Fraction Stereotactic Body Radiation Therapy in Apical Lung Tumors. Pract Radiat Oncol 2022; 13:e246-e253. [PMID: 36581198 DOI: 10.1016/j.prro.2022.12.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Revised: 11/30/2022] [Accepted: 12/02/2022] [Indexed: 12/27/2022]
Abstract
PURPOSE The objective of this study was to evaluate the incidence of brachial plexus injury (BPI) after single-fraction stereotactic body radiation therapy (SBRT) to apical lung tumors. METHODS AND MATERIALS A retrospective cohort analysis was performed of all patients treated with single-fraction lung SBRT at our institution from 2007 to 2022. Apical tumors were identified as those with an epicenter located above the arch of the aorta. Dosimetric analysis of dose to the brachial plexus (BP) was done using both the subclavian vessel (SCV) surrogate structure and anatomic BP. BPI was assessed per Common Terminology Criteria for Adverse Events, version 4.0, as regional paresthesia, marked discomfort and muscle weakness, and limited movement of the arm or hand. RESULTS A total of 45 patients met inclusion criteria with median follow-up of 21 months. There were 9 patients who exceeded the BP dose constraint using the SCV or anatomic BP volume. Only 1 patient (2.2%) developed grade 2 BPI, occurring 7 months after SBRT. Dose to the anatomic BP for the affected patient was 26.39 Gy. For the entire cohort, the median SCV and anatomic maximum BP doses were 8.44 and 7.14 Gy, respectively. CONCLUSIONS There is considerable variability in dose delivered to the BP after SBRT to apical lung tumors. BPI after single-fraction SBRT to apical tumors is rare and rates are comparable with those reported with multifraction regimens.
Collapse
Affiliation(s)
- Austin J Iovoli
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York
| | - Sharan Prasad
- College of Human Ecology, Cornell University, Ithaca, New York
| | - Harish K Malhotra
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York
| | - Nadia K Malik
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York
| | - Simon Fung-Kee-Fung
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York
| | - Anurag K Singh
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York
| | - Mark K Farrugia
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
| |
Collapse
|
3
|
Singh AK, Hennon M, Ma SJ, Demmy TL, Picone A, Dexter EU, Nwogu C, Attwood K, Tan W, Hermann GM, Fung-Kee-Fung S, Malhotra HK, Yendamuri S, Gomez-Suescun JA. A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer. BMC Cancer 2018; 18:1183. [PMID: 30497431 PMCID: PMC6267846 DOI: 10.1186/s12885-018-5039-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2018] [Accepted: 11/04/2018] [Indexed: 12/25/2022] Open
Abstract
Background Standard therapy for stage III non-small cell lung cancer with chemotherapy and conventional radiation has suboptimal outcomes. We hypothesized that a combination of surgery followed by stereotactic body radiation therapy (SBRT) would be a safe alternative. Methods Patients with stage IIIA (multistation N2) or IIIB non-small cell lung cancer were enrolled from March 2013 to December 2015. The protocol included transcervical extended mediastinal lymphadenectomy (TEMLA) followed by surgical resection, 10 Gy SBRT directed to the involved mediastinum/hilar stations and/or positive surgical margins, and adjuvant systemic therapy. Patients not suitable for anatomic lung resection were treated with 30 Gy to the primary tumor. The primary efficacy end-point was the proportion of patients with grade 3 or higher adverse events (AE) or toxicities. Results Of 10 patients, 7 patients underwent neoadjuvant chemotherapy. All patients had TEMLA. Nine of 10 patients underwent surgical resection. The remaining patient had an unresectable tumor and received 30 Gy SBRT to the primary lesion. All patients had post-operative SBRT. Median follow-up was 18 months. There were no perioperative mortalities. Six patients had any grade 3 AEs with no grade 4–5 AEs. Of these, 4 were not attributable to radiation. Pulmonary-related grade 3 AEs were experienced by 2 patients. There were no failures within the 10 Gy volume. Overall survival and progression-free survival rates at 2 years were 68% (90% CI 36–86) and 40% (90% CI 16–63), respectively. Conclusions In carefully selected patients with locally advanced non-small cell lung cancer, combining surgery with SBRT was well tolerated with no local failure. Trial registration ClinicalTrials.gov identifying number NCT01781741. Registered February 1, 2013.
Collapse
Affiliation(s)
- Anurag K Singh
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA.
| | - Mark Hennon
- Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Sung Jun Ma
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Todd L Demmy
- Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Anthony Picone
- Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Elizabeth U Dexter
- Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Chumy Nwogu
- Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Kristopher Attwood
- Department of Biostatistics, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Wei Tan
- Department of Biostatistics, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Gregory M Hermann
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Simon Fung-Kee-Fung
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Harish K Malhotra
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Sai Yendamuri
- Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| | - Jorge A Gomez-Suescun
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, USA
| |
Collapse
|
4
|
Mohatt DJ, Ma T, Wiant DB, Islam NM, Gomez J, Singh AK, Malhotra HK. Technical and dosimetric implications of respiratory induced density variations in a heterogeneous lung phantom. Radiat Oncol 2018; 13:165. [PMID: 30180894 PMCID: PMC6124019 DOI: 10.1186/s13014-018-1110-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Accepted: 08/21/2018] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Stereotactic Body Radiotherapy (SBRT) is an ablative dose delivery technique which requires the highest levels of precision and accuracy. Modeling dose to a lung treatment volume has remained a complex and challenging endeavor due to target motion and the low density of the surrounding media. When coupled together, these factors give rise to pulmonary induced tissue heterogeneities which can lead to inaccuracies in dose computation. This investigation aims to determine which combination of imaging techniques and computational algorithms best compensates for time dependent lung target displacements. METHODS A Quasar phantom was employed to simulate respiratory motion for target ranges up to 3 cm. 4DCT imaging was used to generate Average Intensity Projection (AIP), Free Breathing (FB), and Maximum Intensity Projection (MIP) image sets. In addition, we introduce and compare a fourth dataset for dose computation based on a novel phase weighted density (PWD) technique. All plans were created using Eclipse version 13.6 treatment planning system and calculated using the Analytical Anisotropic Algorithm and Acuros XB. Dose delivery was performed using Truebeam STx linear accelerator where radiochromic film measurements were accessed using gamma analysis to compare planned versus delivered dose. RESULTS In the most extreme case scenario, the mean CT difference between FB and MIP datasets was found to be greater than 200 HU. The near maximum dose discrepancies between AAA and AXB algorithms were determined to be marginal (< 2.2%), with a greater variability occurring within the near minimum dose regime (< 7%). Radiochromatic film verification demonstrated all AIP and FB based computations exceeded 98% passing rates under conventional radiotherapy tolerances (gamma 3%, 3 mm). Under more stringent SBRT tolerances (gamma 3%, 1 mm), the AIP and FB based treatment plans exhibited higher pass rates (> 85%) when compared to MIP and PWD (< 85%) for AAA computations. For AXB, however, the delivery accuracy for all datasets were greater than 85% (gamma 3%,1 mm), with a corresponding reduction in overall lung irradiation. CONCLUSIONS Despite the substantial density variations between computational datasets over an extensive range of target movement, the dose difference between CT datasets is small and could not be quantified with ion chamber. Radiochromatic film analysis suggests the optimal CT dataset is dependent on the dose algorithm used for evaluation. With AAA, AIP and FB resulted in the best conformance between measured versus calculated dose for target motion ranging up to 3 cm under both conventional and SBRT tolerance criteria. With AXB, pass rates improved for all datasets with the PWD technique demonstrating slightly better conformity over AIP and FB based computations (gamma 3%, 1 mm). As verified in previous studies, our results confirm a clear advantage in delivery accuracy along with a relative decrease in calculated dose to the lung when using Acuros XB over AAA.
Collapse
Affiliation(s)
- Dennis J Mohatt
- Medical Physics Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, 14214-3005, USA. .,Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14293, USA.
| | - Tianjun Ma
- Medical Physics Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, 14214-3005, USA.,Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14293, USA
| | - David B Wiant
- Radiation Oncology, Cone Health Cancer Center, Greensboro, NC, 27403, USA
| | - Naveed M Islam
- Medical Physics Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, 14214-3005, USA.,Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14293, USA
| | - Jorge Gomez
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14293, USA
| | - Anurag K Singh
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14293, USA
| | - Harish K Malhotra
- Medical Physics Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, 14214-3005, USA.,Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14293, USA
| |
Collapse
|
5
|
Cummings MA, Ma SJ, Hermann G, Serra L, Syed Y, Malhotra HK, Chen Y, Milano MT, Gomez-Suescun JA, Singh DP, Singh AK. Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-small-cell Lung Cancer: A Two-institution Propensity-matched Analysis. Clin Lung Cancer 2018; 19:511-517. [PMID: 30131257 DOI: 10.1016/j.cllc.2018.07.006] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2018] [Revised: 07/17/2018] [Accepted: 07/20/2018] [Indexed: 12/20/2022]
Abstract
PURPOSE To evaluate differences in local control (LC), disease-specific (DC), and overall survival (OS) of patients with early-stage non-small-cell lung cancer (NSCLC) treated with single- (SF) versus 5-fraction (FF) stereotactic body radiation therapy (SBRT) at 2 institutions. PATIENTS AND METHODS Peripheral early-stage NSCLC cases treated with a median dose of 30 Gy in SF or a median dose of 50 Gy in FF were included per institutional practice. Kaplan-Meier and Cox models were used to assess survival. A matched-pair analysis was performed to account for imbalances. Toxicities including Common Terminology Criteria for Adverse Events (CTCAE) grade 3 pneumonitis, chest wall pain requiring long-acting narcotics, and hospitalization for respiratory events 6 months posttreatment were recorded. RESULTS A total of 163 lesions were treated between 2007 and 2015; 65 received SF SBRT and 98 received FF SBRT. Most tumors were T1 (n = 92) and T2 (n = 34) lesions and had adenocarcinoma (n = 77) and squamous cell carcinoma (n = 46) histologies, respectively. In the matched cohort, there were no differences in OS, LC, DC, or progression-free survival between the groups. LC and OS at 1 year in the matched cohort was 95% and 88%, and 87% and 84% in the SF and FF cohorts, respectively. There was 1 grade 3 pneumonitis in the FF group, and 9 total hospitalizations post-SBRT, 3 (5%) in the SF group and 6 (6%) in the FF group. CONCLUSIONS No statistically significant differences were seen in LC or DC following SF or FF SBRT in this matched cohort of peripheral lesions. No grade 4 or higher toxicities were reported.
Collapse
Affiliation(s)
- Michael A Cummings
- Department of Radiation Oncology, Wilmot Cancer Institute, Rochester, NY.
| | - Sung Jun Ma
- University at Buffalo, The State University of New York Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Gregory Hermann
- University at Buffalo, The State University of New York Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Lucas Serra
- University at Buffalo, The State University of New York Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Yusef Syed
- University at Buffalo, The State University of New York Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Harish K Malhotra
- Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Yuhchyau Chen
- Department of Radiation Oncology, Wilmot Cancer Institute, Rochester, NY
| | - Michael T Milano
- Department of Radiation Oncology, Wilmot Cancer Institute, Rochester, NY
| | - Jorge A Gomez-Suescun
- University at Buffalo, The State University of New York Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| | - Deepinder P Singh
- Department of Radiation Oncology, Wilmot Cancer Institute, Rochester, NY
| | - Anurag K Singh
- University at Buffalo, The State University of New York Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY; Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
| |
Collapse
|
6
|
Abstract
Chemoradiation plays a core role in the definitive and preoperative management of esophageal cancer. Remarkable advances in technology now allow for the implementation of intensity modulated radiation therapy (IMRT) to minimize normal organ damage and to maximize coverage of tumorous targets. While IMRT is commonly accepted in the treatment of prostate and head and neck cancers, there have been clinical and dosimetric studies supporting the use of IMRT in esophagus cancer. In addition, the IMRT technique was recently enhanced by the availability of volumetric intensity modulated arc therapy (VMAT). VMAT may allow for faster delivery of IMRT with the advantage of normal organ protection compared to the stop-and-shoot IMRT, with faster delivery time and reduced monitor units. This review summarizes the use of chemoradiation in esophageal cancer, discusses current dosimetric data and clinical outcomes with the use of IMRT, and reviews IMRT as part of multi-modality treatment in esophageal cancer.
Collapse
Affiliation(s)
- Johnny C Yap
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
| | - Harish K Malhotra
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
| | - Gary Y Yang
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
| |
Collapse
|
7
|
Mohatt DJ, Keim JM, Greene MC, Patel-Yadav A, Gomez JA, Malhotra HK. An investigation into the range dependence of target delineation strategies for stereotactic lung radiotherapy. Radiat Oncol 2017; 12:166. [PMID: 29100548 PMCID: PMC5670725 DOI: 10.1186/s13014-017-0907-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2017] [Accepted: 10/23/2017] [Indexed: 12/25/2022] Open
Abstract
Background The “gold standard” approach for defining an internal target volume (ITV) is using 10 gross tumor volume (GTV) phases delineated over the course of one respiratory cycle. However, different sites have adopted several alternative techniques which compress all temporal information into one CT image set to optimize work flow efficiency. The purpose of this study is to evaluate alternative target segmentation strategies with respect to the 10 phase gold standard. Methods A Quasar respiratory motion phantom was employed to simulate lung tumor movement. Utilizing 4DCT imaging, a gold standard ITV was created by merging 10 GTV time resolved image sets. Four alternative planed ITV’s were compared using free breathing (FB), average intensity projection (AIP), maximum image projection (MIP), and an augmented FB (FB-Aug) set where the ITV included structures from FB plus max-inhale/exhale image sets. Statistical analysis was performed using the Dice similarity coefficient (DSC). Seventeen patients previously treated for lung SBRT were also included in this retroactive study. Results PTV’s derived from the FB image set are the least comparable with the 10 phase benchmark (DSC = 0.740-0.408). For phantom target motion greater than 1 cm, FB and AIP ITV delineation exceeded the 10 phase benchmark by 2% or greater, whereas MIP target segmentation was found to be consistently within 2% agreement with the gold standard (DSC > 0.878). Clinically, however, the FB-Aug method proved to be most favorable for tumor movement up to 2 cm (DSC = 0.881 ± 0.056). Conclusion Our results indicate the range of tumor motion dictates the accuracy of the defined PTV with respect to the gold standard. When considering delineation efficiency relative to the 10 phase benchmark, the FB-Aug technique presents a potentially proficient and viable clinical alternative. Among various techniques used for image segmentation, a judicious balance between accuracy and efficiency is inherently required to account for tumor trajectory, range and rate of mobility.
Collapse
Affiliation(s)
- Dennis J Mohatt
- Department of Physiology and Biophysics, University at Buffalo, NY, Buffalo, 14214-3005, USA.
| | - John M Keim
- Department of Radiation Medicine, Roswell Park Cancer Institute, NY, Buffalo, 14293, USA
| | - Mathew C Greene
- Department of Radiation Medicine, Roswell Park Cancer Institute, NY, Buffalo, 14293, USA
| | - Ami Patel-Yadav
- Department of Radiation Medicine, Roswell Park Cancer Institute, NY, Buffalo, 14293, USA
| | - Jorge A Gomez
- Department of Radiation Medicine, Roswell Park Cancer Institute, NY, Buffalo, 14293, USA
| | - Harish K Malhotra
- Department of Physiology and Biophysics, University at Buffalo, NY, Buffalo, 14214-3005, USA.,Department of Radiation Medicine, Roswell Park Cancer Institute, NY, Buffalo, 14293, USA
| |
Collapse
|
8
|
Affiliation(s)
- Jing Cai
- Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710 (Tel: 434-982-0161; E-mail: )
| | - Harish K Malhotra
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263 (Tel: 716-845-1475; E-mail: )
| | | |
Collapse
|
9
|
Rauschenbach BM, Mackowiak L, Malhotra HK. A dosimetric comparison of three-dimensional conformal radiotherapy, volumetric-modulated arc therapy, and dynamic conformal arc therapy in the treatment of non-small cell lung cancer using stereotactic body radiotherapy. J Appl Clin Med Phys 2014; 15:4898. [PMID: 25207575 PMCID: PMC5711086 DOI: 10.1120/jacmp.v15i5.4898] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2014] [Revised: 06/16/2014] [Accepted: 06/10/2014] [Indexed: 12/14/2022] Open
Abstract
This study evaluates three‐dimensional conformal radiotherapy (3D CRT), volumetric‐ modulated arc therapy (VMAT), and dynamic conformal arc therapy (DCAT) planning techniques using dosimetric indices from Radiation Therapy Oncology Group (RTOG) protocols 0236, 0813, and 0915 for the treatment of early‐stage non‐small cell lung cancer (NSCLC) using stereotactic body radiotherapy (SBRT). Twenty‐five clinical patients, five per lung lobe, previously treated for NSCLC using 3D CRT SBRT under respective RTOG protocols were replanned with VMAT and DCAT techniques. All plans were compared using respective RTOG dosimetric indices. High‐ and low‐dose spillage improved for VMAT and DCAT plans, though only VMAT was able to improve dose to all organs at risk (OARs). DCAT was only able to provide a minimal improvement in dose to the heart and ipsilateral brachial plexus. Mean bilateral, contralateral, and V20 (percentage of bilateral lung receiving at least 20 Gy dose) doses were reduced with VMAT in comparison with respective 3D CRT clinical plans. Though some of the DCAT plans had values for the above indices slightly higher than their respective 3D CRT plans, they still were able to meet the RTOG constraints. VMAT and DCAT were able to offer improved skin dose by 1.1% and 11%, respectively. Monitor units required for treatment delivery increased with VMAT by 41%, but decreased with DCAT by 26%. VMAT and DCAT provided improved dose distributions to the PTV, but only VMAT was consistently superior in sparing dose to OARs in all the five lobes. DCAT should still remain an alternative to 3D CRT in facilities that do not have VMAT or intensity‐modulated radiotherapy (IMRT) capabilities. PACS numbers: 87.53.Ly, 87.55.dk, 87.55.D‐
Collapse
|
10
|
May KS, Yang GY, Khushalani NI, Chandrasekhar R, Wilding GE, Flaherty L, Malhotra HK, Russo RC, Warner JC, Yap JC, Iyer RV, Nwogu CE, Yendamuri SS, Gibbs JF, Nava HR, Lamonica D, Thomas CR. Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies. J Gastrointest Oncol 2012; 1:7-15. [PMID: 22811800 DOI: 10.3978/j.issn.2078-6891.2010.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/22/2010] [Accepted: 03/27/2010] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Information on differential renal function following abdominal chemoradiation is limited. This study evaluated the association between renal function as measured by biochemical endpoints and scintigraphy and dose volume parameters in patients with gastrointestinal malignancies. MATERIALS AND METHODS Patients who received abdominal chemoradiation between 2002 and 2009 were identified for this study. Technetium(99m) MAG-3 scintigraphy and laboratory data were obtained prior to and after chemoradiation in 6 month intervals. Factors assessed included age, gender, hypertension, diabetes, and dose volume parameters. Renal function was assessed by biochemical endpoints and renal scintigraphy. RESULTS Significant reductions in relative renal function of the primarily irradiated kidney and creatinine clearance were seen. Split renal function decreased from 49.75% pre-radiation to 47.74% and 41.28% at 6-12 months and >12 months post-radiation (P=0.0184). Creatinine clearance declined from 90.67ml/min pre-radiation to 82.23ml/min and 74.54ml/min at 6-12 months and >12 months post-radiation (P<0.0001). Univariate analysis of patients who had at least one post-radiation renogram showed the percent volumes of the primarily irradiated kidney receiving ≥ 25 Gy (V(25)) and 40 Gy (V(40)) were significantly associated with ≥5% decrease in relative renal function (P=0.0387 and P=0.0438 respectively). CONCLUSION Decline in split renal function using Technetium(99m) MAG-3 scintigraphy correlates with decrease in creatinine clearance and radiation dose-volume parameters following abdominal chemoradiation. Change in split perfusion can be detected as early as 6 months post-radiation. Scintigraphy may provide early determination and quantification of subclinical renal injury prior to clinical evidence of nephropathy.
Collapse
Affiliation(s)
- Kilian Salerno May
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Bailey DW, Kumaraswamy L, Bakhtiari M, Malhotra HK, Podgorsak MB. EPID dosimetry for pretreatment quality assurance with two commercial systems. J Appl Clin Med Phys 2012; 13:3736. [PMID: 22766944 PMCID: PMC5716510 DOI: 10.1120/jacmp.v13i4.3736] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2011] [Revised: 11/07/2011] [Accepted: 03/13/2012] [Indexed: 11/23/2022] Open
Abstract
This study compares the EPID dosimetry algorithms of two commercial systems for pretreatment QA, and analyzes dosimetric measurements made with each system alongside the results obtained with a standard diode array. 126 IMRT fields are examined with both EPID dosimetry systems (EPIDose by Sun Nuclear Corporation, Melbourne FL, and Portal Dosimetry by Varian Medical Systems, Palo Alto CA) and the diode array, MapCHECK (also by Sun Nuclear Corporation). Twenty-six VMAT arcs of varying modulation complexity are examined with the EPIDose and MapCHECK systems. Optimization and commissioning testing of the EPIDose physics model is detailed. Each EPID IMRT QA system is tested for sensitivity to critical TPS beam model errors. Absolute dose gamma evaluation (3%, 3 mm, 10% threshold, global normalization to the maximum measured dose) yields similar results (within 1%-2%) for all three dosimetry modalities, except in the case of off-axis breast tangents. For these off-axis fields, the Portal Dosimetry system does not adequately model EPID response, though a previously-published correction algorithm improves performance. Both MapCHECK and EPIDose are found to yield good results for VMAT QA, though limitations are discussed. Both the Portal Dosimetry and EPIDose algorithms, though distinctly different, yield similar results for the majority of clinical IMRT cases, in close agreement with a standard diode array. Portal dose image prediction may overlook errors in beam modeling beyond the calculation of the actual fluence, while MapCHECK and EPIDose include verification of the dose calculation algorithm, albeit in simplified phantom conditions (and with limited data density in the case of the MapCHECK detector). Unlike the commercial Portal Dosimetry package, the EPIDose algorithm (when sufficiently optimized) allows accurate analysis of EPID response for off-axis, asymmetric fields, and for orthogonal VMAT QA. Other forms of QA are necessary to supplement the limitations of the Portal Vision Dosimetry system.
Collapse
Affiliation(s)
- Daniel W Bailey
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo NY 14263, USA.
| | | | | | | | | |
Collapse
|
12
|
Nazareth DP, Brunner S, Jones MD, Malhotra HK, Bakhtiari M. Optimization of beam angles for intensity modulated radiation therapy treatment planning using genetic algorithm on a distributed computing platform. J Med Phys 2011; 34:129-32. [PMID: 20098558 PMCID: PMC2807676 DOI: 10.4103/0971-6203.54845] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2008] [Revised: 03/13/2009] [Accepted: 04/21/2009] [Indexed: 11/23/2022] Open
Abstract
Planning intensity modulated radiation therapy (IMRT) treatment involves selection of several angle parameters as well as specification of structures and constraints employed in the optimization process. Including these parameters in the combinatorial search space vastly increases the computational burden, and therefore the parameter selection is normally performed manually by a clinician, based on clinical experience. We have investigated the use of a genetic algorithm (GA) and distributed-computing platform to optimize the gantry angle parameters and provide insight into additional structures, which may be necessary, in the dose optimization process to produce optimal IMRT treatment plans. For an IMRT prostate patient, we produced the first generation of 40 samples, each of five gantry angles, by selecting from a uniform random distribution, subject to certain adjacency and opposition constraints. Dose optimization was performed by distributing the 40-plan workload over several machines running a commercial treatment planning system. A score was assigned to each resulting plan, based on how well it satisfied clinically-relevant constraints. The second generation of 40 samples was produced by combining the highest-scoring samples using techniques of crossover and mutation. The process was repeated until the sixth generation, and the results compared with a clinical (equally-spaced) gantry angle configuration. In the sixth generation, 34 of the 40 GA samples achieved better scores than the clinical plan, with the best plan showing an improvement of 84%. Moreover, the resulting configuration of beam angles tended to cluster toward the patient's sides, indicating where the inclusion of additional structures in the dose optimization process may avoid dose hot spots. Additional parameter selection in IMRT leads to a large-scale computational problem. We have demonstrated that the GA combined with a distributed-computing platform can be applied to optimize gantry angle selection within a reasonable amount of time.
Collapse
Affiliation(s)
- Daryl P Nazareth
- Department of Radiation Medicine, Roswell Park Cancer Institute, Elm & Carlton Sts, Buffalo NY 14263, USA
| | | | | | | | | |
Collapse
|
13
|
Wu V, Podgorsak MB, Tran TA, Malhotra HK, Wang IZ. Dosimetric impact of image artifact from a wide-bore CT scanner in radiotherapy treatment planning. Med Phys 2011; 38:4451-63. [DOI: 10.1118/1.3604150] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
14
|
Bakhtiari M, Kumaraswamy L, Bailey DW, de Boer S, Malhotra HK, Podgorsak MB. Using an EPID for patient-specific VMAT quality assurance. Med Phys 2011; 38:1366-73. [PMID: 21520847 DOI: 10.1118/1.3552925] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE A patient-specific quality assurance (QA) method was developed to verify gantry-specific individual multileaf collimator (MLC) apertures (control points) in volumetric modulated arc therapy (VMAT) plans using an electronic portal imaging device (EPID). METHODS VMAT treatment plans were generated in an Eclipse treatment planning system (TPS). DICOM images from a Varian EPID (aS1000) acquired in continuous acquisition mode were used for pretreatment QA. Each cine image file contains the grayscale image of the MLC aperture related to its specific control point and the corresponding gantry angle information. The TPS MLC file of this RapidArc plan contains the leaf positions for all 177 control points (gantry angles). In-house software was developed that interpolates the measured images based on the gantry angle and overlays them with the MLC pattern for all control points. The 38% isointensity line was used to define the edge of the MLC leaves on the portal images. The software generates graphs and tables that provide analysis for the number of mismatched leaf positions for a chosen distance to agreement at each control point and the frequency in which each particular leaf mismatches for the entire arc. RESULTS Seven patients plans were analyzed using this method. The leaves with the highest mismatched rate were found to be treatment plan dependent. CONCLUSIONS This in-house software can be used to automatically verify the MLC leaf positions for all control points of VMAT plans using cine images acquired by an EPID.
Collapse
Affiliation(s)
- M Bakhtiari
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
| | | | | | | | | | | |
Collapse
|
15
|
Hira M, Podgorsak MB, Jaggernauth W, Malhotra HK. Measurement of dose perturbation around shielded ovoids in high-dose-rate brachytherapy. Brachytherapy 2011; 10:232-41. [DOI: 10.1016/j.brachy.2010.08.008] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2010] [Revised: 07/30/2010] [Accepted: 08/11/2010] [Indexed: 11/17/2022]
|
16
|
Schildkraut JS, Prosser N, Savakis A, Gomez J, Nazareth D, Singh AK, Malhotra HK. Level-set segmentation of pulmonary nodules in megavolt electronic portal images using a CT prior. Med Phys 2011; 37:5703-10. [PMID: 21158282 DOI: 10.1118/1.3495538] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE Pulmonary nodules present unique problems during radiation treatment due to nodule position uncertainty that is caused by respiration. The radiation field has to be enlarged to account for nodule motion during treatment. The purpose of this work is to provide a method of locating a pulmonary nodule in a megavolt portal image that can be used to reduce the internal target volume (ITV) during radiation therapy. A reduction in the ITV would result in a decrease in radiation toxicity to healthy tissue. METHODS Eight patients with nonsmall cell lung cancer were used in this study. CT scans that include the pulmonary nodule were captured with a GE Healthcare LightSpeed RT 16 scanner. Megavolt portal images were acquired with a Varian Trilogy unit equipped with an AS1000 electronic portal imaging device. The nodule localization method uses grayscale morphological filtering and level-set segmentation with a prior. The treatment-time portion of the algorithm is implemented on a graphical processing unit. RESULTS The method was retrospectively tested on eight cases that include a total of 151 megavolt portal image frames. The method reduced the nodule position uncertainty by an average of 40% for seven out of the eight cases. The treatment phase portion of the method has a subsecond execution time that makes it suitable for near-real-time nodule localization. CONCLUSIONS A method was developed to localize a pulmonary nodule in a megavolt portal image. The method uses the characteristics of the nodule in a prior CT scan to enhance the nodule in the portal image and to identify the nodule region by level-set segmentation. In a retrospective study, the method reduced the nodule position uncertainty by an average of 40% for seven out of the eight cases studied.
Collapse
|
17
|
Tran TA, Stanley TR, Malhotra HK, De Boer SF, Prasad D, Podgorsak MB. Target and peripheral dose during patient repositioning with the Gamma Knife automatic positioning system (APS) device. J Appl Clin Med Phys 2010; 11:3150. [PMID: 20160701 PMCID: PMC5719780 DOI: 10.1120/jacmp.v11i1.3150] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2009] [Revised: 10/28/2009] [Accepted: 10/28/2009] [Indexed: 11/23/2022] Open
Abstract
The GammaPlan treatment planning system does not account for the leakage and scatter dose during APS repositioning. In this study, the dose delivered to the target site and its periphery from the defocus stage and intershot couch transit (couch motion from the focus to defocus position and back) associated with APS repositioning are measured for the Gamma Knife model 4C. A stereotactic head‐frame was attached to a Leksell 16 cm diameter spherical phantom with a calibrated ion chamber at its center. Using a fiducial box, CT images of the phantom were acquired and registered in the GammaPlan treatment planning system to determine the coordinates of the target (center of the phantom). An absorbed dose of 10 Gy to the 50% isodose line was prescribed to the target site for all measurements. Plans were generated for the 8, 14 and 18 mm collimator helmets to determine the relationship of measured dose to the number of repositions of the APS system and to the helmet size. The target coordinate was identical throughout entire study and there was no movement of the APS between various shots. This allowed for measurement of intershot transit dose at the target site and its periphery. The couch was paused in the defocus position, allowing defocus dose measurements at the intracranial target and periphery. Measured dose increases with frequency of repositioning and with helmet collimator size. During couch transit, the target receives more dose than peripheral regions; however, in the defocus position, the greatest dose is superior to the target site. The automatic positioning system for the Leksell Gamma Knife model 4C results in an additional dose of up to 3.87±0.07%,4.97±0.04%, and 5.71±0.07% to the target site; its periphery receives additional dose that varies depending on its position relative to the target. There is also dose contribution to the patient in the defocus position, where the APS repositions the patient from one treatment coordinate to another. This may be important for treatment areas around critical structures within the brain. Further characterization of the defocus and transit exposures and development of a dose calculation algorithm to account for these doses would improve the accuracy of the delivered plan. PACS numbers: 87.53.‐j, 87.53.Bn, 87.53.Dq, 87.53.Ly
Collapse
Affiliation(s)
- Tuan-Anh Tran
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
| | | | | | | | | | | |
Collapse
|
18
|
Wang Z, Jaggernauth W, Malhotra HK, Podgorsak MB. Variability of marker-based rectal dose evaluation in HDR cervical brachytherapy. Med Dosim 2009; 35:269-73. [PMID: 19944586 DOI: 10.1016/j.meddos.2009.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2008] [Revised: 05/07/2009] [Accepted: 08/31/2009] [Indexed: 11/18/2022]
Abstract
In film-based intracavitary brachytherapy for cervical cancer, position of the rectal markers may not accurately represent the anterior rectal wall. This study was aimed at analyzing the variability of rectal dose estimation as a result of interfractional variation of marker placement. A cohort of five patients treated with multiple-fraction tandem and ovoid high-dose-rate (HDR) brachytherapy was studied. The cervical os point and the orientation of the applicators were matched among all fractional plans for each patient. Rectal points obtained from all fractions were then input into each clinical treated plan. New fractional rectal doses were obtained and a new cumulative rectal dose for each patient was calculated. The maximum interfractional variation of distances between rectal dose points and the closest source positions was 1.1 cm. The corresponding maximum variability of fractional rectal dose was 65.5%. The percentage difference in cumulative rectal dose estimation for each patient was 5.4%, 19.6%, 34.6%, 23.4%, and 13.9%, respectively. In conclusion, care should be taken when using rectal markers as reference points for estimating rectal dose in HDR cervical brachytherapy. The best estimate of true rectal dose for each fraction should be determined by the most anterior point among all fractions.
Collapse
Affiliation(s)
- Zhou Wang
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
| | | | | | | |
Collapse
|
19
|
McCloskey SA, Tchabo NE, Malhotra HK, Odunsi K, Rodabaugh K, Singhal P, Lele S, Jaggernauth W. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecol Oncol 2009; 116:404-7. [PMID: 19944453 DOI: 10.1016/j.ygyno.2009.06.027] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2009] [Revised: 06/16/2009] [Accepted: 06/19/2009] [Indexed: 11/20/2022]
Abstract
OBJECTIVE Controversy exists regarding optimal management of high risk localized endometrial cancer. Given that vaginal brachytherapy (VB) alone is used routinely at our institution, we retrospectively reviewed our outcomes among high risk patients defined according to the PORTEC, GOG 99, and/or Aalders randomized trials of pelvic radiation versus observation to determine if acceptable rates of locoregional control could be achieved with vaginal brachytherapy alone in this highest risk patient population. METHODS The Roswell Park Cancer Institute hospital tumor registry was used to identify all patients with Stage I or IIA endometrial cancer treated between January 1992 and June 2006. A total of 464 patients were identified. Of 261 patients who received post-operative RT, 225 received VB alone. Of those 225, 87 met the high risk criteria as designated by PORTEC (at least 2 of the following high risk features: age>60, Grade 3, and/or myometrial invasion >or=Occurrences of the mathematical operator' (='were changed to 'OE'. Please check.-->50%), GOG 99 (any age with 3 high risk features: Grade 2-3, >66% myometrial invasion, and/or LVSI; age >or=50 with 2 high risk features; or age >or=70 with 1 high risk feature), and/or Aalders (Stage IC, Grade 3). Descriptive recurrence statistics are provided. RESULTS Among 87 high risk patients treated with VB alone, 36, 77, and 14 were high risk per PORTEC, GOG 99, and Aalders respectively. Forty (46%) underwent pelvic lymph node dissection. With a median follow-up of 52 months, 3 (3.4%) pelvic recurrences were observed including 1 vaginal recurrence, 1 pelvic recurrence, and 1 local recurrence involving both the vagina and pelvis. All 3 local recurrences were successfully salvaged with pelvic RT+/-surgery. CONCLUSIONS This represents one of the largest known series of high risk localized endometrial cancer treated with VB alone. The observed 3.4% locoregional recurrence compares favorably with the 5% locoregional recurrence noted among the highest risk patients receiving pelvic RT in the PORTEC, GOG 99, and Aalders randomized trials. In this single institution experience, the 3 local recurrences were salvaged. Based on these findings, we will continue to use VB alone in the adjuvant setting for patients with high risk localized endometrial cancer.
Collapse
Affiliation(s)
- Susan A McCloskey
- Roswell Park Cancer Institute, Department of Radiation Medicine, Buffalo, NY 14263, USA.
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Oh M, Wang Z, Malhotra HK, Jaggernauth W, Podgorsak MB. Impact of Surface Curvature on Dose Delivery in Intraoperative High-Dose-Rate Brachytherapy. Med Dosim 2009; 34:63-74. [DOI: 10.1016/j.meddos.2008.05.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2007] [Revised: 05/06/2008] [Accepted: 05/14/2008] [Indexed: 11/27/2022]
|
21
|
Wang Z, Jaggernauth W, Malhotra HK, Podgorsak MB. MO-D-AUD B-07: Analysis of Rectal Dose Variability Due to Inter-Fractional Variations of Rectal Marker Positioning in Film-Based HDR Cervical Brachytherapy. Med Phys 2008. [DOI: 10.1118/1.2962348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
22
|
Malhotra HK, Avadhani JS, de Boer SF, Jaggernauth W, Kuettel MR, Podgorsak MB. Duplicating a tandem and ovoids distribution with intensity-modulated radiotherapy: a feasibility study. J Appl Clin Med Phys 2007; 8:91-98. [PMID: 17712303 PMCID: PMC5722607 DOI: 10.1120/jacmp.v8i3.2450] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2006] [Revised: 03/28/2007] [Accepted: 03/28/2007] [Indexed: 11/23/2022] Open
Abstract
Brachytherapy plays an important role in the definitive treatment of cervical cancers by radiotherapy. In the present study, we investigated whether sliding‐window intensity‐modulated radiation therapy (IMRT) can achieve a pear‐shaped distribution with a similar sharp dose falloff identical to that of brachytherapy. The computed tomography scans of a tandem and ovoid patient were pushed to both a high dose rate (HDR) and an IMRT treatment planning system (TPS) after the rectum, bladder, and left and right femoral heads had been outlined, ensuring identical structures in both planning systems. A conventional plan (7 Gy in 5 fractions, defined as the average dose to the left and right point A) was generated for HDR treatment. The 150%, 125%, 100%, 75%, 50%, and 25% isodose curves were drawn on each slice and then transferred to the IMRT TPS. The 100% isodose envelope from the HDR plan was the target for IMRT planning. A 7‐field IMRT plan using 6‐MV X‐ray beams was generated and compared with the HDR plan using isodose conformity to the target and 125% volume, dose– volume histograms, and integral dose. The resulting isodose distribution demonstrated good agreement between the HDR and IMRT plans in the 100% and 125% isodose range. The dose falloff in the HDR plan was much steeper than that in the IMRT plan, but it also had a substantially higher maximum dose. Integral dose for the target, rectum, and bladder were found to be 6.69 J, 1.07 J, and 1.02 J in the HDR plan; the respective values for IMRT were 3.47 J, 1.79 J, and 1.34 J. Our preliminary results indicate that the HDR dose distribution can be replicated using a standard sliding‐window IMRT dose delivery technique for points lying closer to the three‐dimensional isodose envelope surrounding point A. Differences in radiobiology and patient positioning between the two techniques merit further consideration. PACS: 87.53.Jw
Collapse
Affiliation(s)
- Harish K. Malhotra
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew YorkU.S.A.
| | | | - Steven F. de Boer
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew YorkU.S.A.
| | | | - Michael R. Kuettel
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew YorkU.S.A.
| | - Matthew B. Podgorsak
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew YorkU.S.A.
| |
Collapse
|
23
|
Wang Z, Jaggernauth W, Malhotra HK, Podgorsak MB. SU-FF-T-445: Variations of Rectal Dose Estimation Using Rectal Markers in HDR Cervical Brachytherapy. Med Phys 2007. [DOI: 10.1118/1.2761170] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
24
|
Wang Z, Rajagopalan B, Malhotra HK, Kuettel MR, Podgorsak MB. The effect of positional realignment on dose delivery to the prostate and organs-at-risk for 3DCRT. Med Dosim 2007; 32:1-6. [PMID: 17317528 DOI: 10.1016/j.meddos.2006.08.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2005] [Revised: 06/01/2006] [Accepted: 08/08/2006] [Indexed: 11/27/2022]
Abstract
In this study, we evaluate the impact of daily image-guided patient repositioning on dose delivery to prostate and sensitive organs in the treatment of prostate carcinoma with 3-dimensional conformal radiation therapy (3DCRT). Five patients with substantial ultrasound-documented interfractional prostate motion during their 3DCRT treatment course were selected. Starting with the original treatment plan, 2 additional plans were retrospectively generated for each patient. In one set, organ contours were moved for each fraction, thus simulating positioning with misalignment caused by organ motion if ultrasound guidance were not used. In a second set of plans, the isocenter was shifted, as were the organ contours, simulating realignment based on the ultrasound image. In all cases, the number of planned monitor units was set to those of the original plan. For a given patient, isodose distributions, dose-volume histograms (DVHs), equivalent uniform dose (EUD) for prostate, and generalized equivalent uniform dose (gEUDs) for bladder and rectum were calculated for each fraction and then combined for each shift condition. In all reconstructed plans, the results show no substantial changes in dose coverage of the prostate <0.21% change in EUD) compared to the original plan. However, in some cases with no realignment, a larger volume of the bladder or rectum gets higher dose, with the consequent gEUD for each organ significantly greater compared to the original plan.
Collapse
Affiliation(s)
- Zhou Wang
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
| | | | | | | | | |
Collapse
|
25
|
Tripp P, Malhotra HK, Javle M, Shaukat A, Russo R, De Boer S, Podgorsak M, Nava H, Yang GY. Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes. Dis Esophagus 2005; 18:400-5. [PMID: 16336612 DOI: 10.1111/j.1442-2050.2005.00523.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
In this paper we determine if preoperative chemoradiation for locally advanced esophageal cancer leads to changes in cardiac ejection fraction. This is a retrospective review of 20 patients treated at our institution for esophageal cancer between 2000 and 2002. Multiple gated acquisition cardiac scans were obtained before and after platinum-based chemoradiation (50.4 Gy). Dose-volume histograms for heart, left ventricle and left anterior descending artery were analyzed. Outcomes assessed included pre- and postchemoradiation ejection fraction ratio and percentage change in ejection fraction postchemoradiation. A statistically significant difference was found between median prechemoradiation ejection fraction (59%) and postchemoradiation ejection fraction (54%) (P = 0.01), but the magnitude of the difference was not clinically significant. Median percentage volume of heart receiving more than 20, 30 and 40 Gy were 61.5%, 58.5% and 53.5%, respectively. Our data showed a clinically insignificant decline in ejection fraction following chemoradiation for esophageal cancer. We did not observe statistically or clinically significant associations between radiation dose to heart, left ventricle or left anterior descending artery and postchemoradiation ejection fraction.
Collapse
Affiliation(s)
- P Tripp
- Department of Radiation Oncology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Malhotra HK, Raina S, Avadhani JS, deBoer S, Podgorsak MB. Technical and dosimetric considerations in IMRT treatment planning for large target volumes. J Appl Clin Med Phys 2005. [DOI: 10.1120/jacmp.2026.25360] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
27
|
Malhotra HK, Raina S, Avadhani JS, deBoer S, Podgorsak MB. Technical and dosimetric considerations in IMRT treatment planning for large target volumes. J Appl Clin Med Phys 2005; 6:77-87. [PMID: 16421502 PMCID: PMC5723450 DOI: 10.1120/jacmp.v6i4.2129] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
Abstract
The maximum width of an intensity‐modulated radiotherapy (IMRT) treatment field is usually smaller than the conventional maximum collimator opening because of design limitations inherent in some multileaf collimators (MLCs). To increase the effective field width, IMRT fluences can be split and delivered with multiple carriage positions. However, not all treatment‐planning systems and MLCs support this technique, and if they do, the maximum field width in multiple carriage position delivery is still significantly less than the maximum collimator opening. For target volumes with dimensions exceeding the field size limit for multiple carriage position delivery, such as liver tumors or other malignancies in the abdominal cavity, IMRT treatment can be accomplished with multiple isocenters or with an extended treatment distance. To study dosimetric statistics of large field IMRT planning, an elliptical volume was chosen as a target within a cubic phantom centered at a depth of 7.5 cm. Multiple three‐field plans (one AP and two oblique beams with 160° between them to avoid parallel opposed geometry) with constraints designed to give 100% dose to the elliptical target were developed. Plans were designed with a single anterior field with dual carriage positions, or with the anterior field split into two fields with separate isocenters 8 cm apart with the beams being forcibly matched at the isocenter or with a 1 cm, 2 cm, 3 cm, and 4 cm overlap. The oblique beams were planned with a single carriage position in all cases. All beams had a nominal energy of 6 MV. In the dual isocenter plans, jaws were manually fixed and dose constraints remained unaltered. Dosimetric statistics were studied for plans developed for treatment delivery using both dynamic leaf motion (sliding window) and multiple static segments (step and shoot) with the number of segments varying from 5 to 30. All plans were analyzed based on the dose homogeneity in the isocenter plane, 2 cm anterior and 2 cm posterior to it, along with their corresponding dose‐volume histograms (DVHs). All the dual isocenter plans had slight underdosage anterior to the match point and slight overdosage posterior to it, while the dual carriage plan had a nice blending of the dose distribution without the accompanying hot or cold spots. Based on the dose statistics, it was noted that the dual isocenter plans can be clinically acceptable if they have at least a 3‐cm overlap. In the case of step and shoot IMRT, the number of segments used in a dual carriage plan was found to affect the overall plan dosimetric indices. PACS number: 87.53.Tf
Collapse
Affiliation(s)
- Harish K. Malhotra
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew York14263U.S.A.
| | - Sanjay Raina
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew York14263U.S.A.
| | - Jaiteerth S. Avadhani
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew York14263U.S.A.
| | - Steven deBoer
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew York14263U.S.A.
| | - Matthew B. Podgorsak
- Department of Radiation MedicineRoswell Park Cancer InstituteBuffaloNew York14263U.S.A.
| |
Collapse
|
28
|
Wang Z, Rajagopalan B, Malhotra HK, Kuettel MR, Podgorsak MB. TU-EE-A4-02: Impact of Ultrasound-Guided Patient Setup On OAR Dose in Conformal Radiation Therapy for Prostate Carcinoma. Med Phys 2005. [DOI: 10.1118/1.1998437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
29
|
Raina S, Avadhani JS, Oh M, Malhotra HK, Jaggernauth W, Kuettel MR, Podgorsak MB. Quantifying IOHDR brachytherapy underdosage resulting from an incomplete scatter environment. Int J Radiat Oncol Biol Phys 2005; 61:1582-6. [PMID: 15817365 DOI: 10.1016/j.ijrobp.2004.10.002] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2004] [Revised: 10/01/2004] [Accepted: 10/08/2004] [Indexed: 10/25/2022]
Abstract
PURPOSE Most brachytherapy planning systems are based on a dose calculation algorithm that assumes an infinite scatter environment surrounding the target volume and applicator. Dosimetric errors from this assumption are negligible. However, in intraoperative high-dose-rate brachytherapy (IOHDR) where treatment catheters are typically laid either directly on a tumor bed or within applicators that may have little or no scatter material above them, the lack of scatter from one side of the applicator can result in underdosage during treatment. This study was carried out to investigate the magnitude of this underdosage. METHODS IOHDR treatment geometries were simulated using a solid water phantom beneath an applicator with varying amounts of bolus material on the top and sides of the applicator to account for missing tissue. Treatment plans were developed for 3 different treatment surface areas (4 x 4, 7 x 7, 12 x 12 cm(2)), each with prescription points located at 3 distances (0.5 cm, 1.0 cm, and 1.5 cm) from the source dwell positions. Ionization measurements were made with a liquid-filled ionization chamber linear array with a dedicated electrometer and data acquisition system. RESULTS Measurements showed that the magnitude of the underdosage varies from about 8% to 13% of the prescription dose as the prescription depth is increased from 0.5 cm to 1.5 cm. This treatment error was found to be independent of the irradiated area and strongly dependent on the prescription distance. Furthermore, for a given prescription depth, measurements in planes parallel to an applicator at distances up to 4.0 cm from the applicator plane showed that the dose delivery error is equal in magnitude throughout the target volume. CONCLUSION This study demonstrates the magnitude of underdosage in IOHDR treatments delivered in a geometry that may not result in a full scatter environment around the applicator. This implies that the target volume and, specifically, the prescription depth (tumor bed) may get a dose significantly less than prescribed. It might be clinically relevant to correct for this inaccuracy.
Collapse
Affiliation(s)
- Sanjay Raina
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY
| | | | | | | | | | | | | |
Collapse
|
30
|
Malhotra HK, Wig NN. Standardized "malhotra-wig vignettes" for research in India : a review with full text. Indian J Psychiatry 2004; 46:52-63. [PMID: 21206776 PMCID: PMC2912678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- H K Malhotra
- Diplomat American Board of Psychiatry and Neurology is a Clinical Assistant Professor of Psychiatry in New Jersey Medical School, University of Medicine and Dentistry of New Jersey at Newark, USA
| | | |
Collapse
|
31
|
Malhotra HK, Inam AS, Chopra HD. Do the psychiatric patients reject themselves? Indian J Psychiatry 1981; 23:44-8. [PMID: 22058514 PMCID: PMC3013184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Five statements measuring social distance from and prejudice against the ex-mentally ill were read to 137 psychiatric patients and relatives from urban background. Their agreement and disagreement with the five statements was analysed and compared with controls from an orthopaedic clinic.Maximum social distance was found on statements about establishing marital relationship with an ex-mental patient. The social distance was found less frequently in working in a mental hospital; sharing same house, falling in love and working with an ex-mental patient respectively. The psychiatric patients and their relatives are more rejecting than the controls.
Collapse
Affiliation(s)
- H K Malhotra
- Instructor, Department of Preventive Medicine and Community Health, College of Medicine and Dentistry of New Jersey at Newark, 100 Bergen Street, Newark, New Jersey 07103, U.S.A
| | | | | |
Collapse
|
32
|
Malhotra HK, Olgiati SG. A survey of therapists' attitudes toward psychiatric patients as hospital volunteers. Hosp Community Psychiatry 1977; 28:345-6. [PMID: 858591 DOI: 10.1176/ps.28.5.345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
33
|
Samuels RM, Malhotra HK, Devanesan MM. A gender dysphoria program in New Jersey. J Med Soc N J 1977; 74:35-9. [PMID: 137984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|